ZD-5522

N/A

Report date: 2023/03/11 18:02:23

NME

Base Information

Drug NameZD-5522

Drug Alias NameZD-5522

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAldose reductase inhibitors

TargetsAldose reductase

Therapy Area/IndicationsDiabetic Neuropathies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAstrazeneca Plc

China Registration ClassN/A

Active CompaniesAstrazeneca Plc

Inactive CompaniesN/A

Active IndicationsDiabetic Neuropathies

Inactive IndicationsN/A

ATC CodeN/A